Latest News about LEXX
Recent news which mentions LEXX
Lexaria Bioscience Committed to Innovation and Improving Quality of Life
December 15, 2021
Tickers
LEXX
From Benzinga
Lexaria's Upcoming R&D Programs Targeting Global Markets Exceeding $160B
December 13, 2021
Tickers
LEXX
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 10, 2021
From Benzinga
52 Biggest Movers From Yesterday
December 09, 2021
From Benzinga
Lexaria Bioscience Featured in Virtual Coverage of Benzinga's Small Cap Conference
December 08, 2021
Tickers
LEXX
From Benzinga
35 Stocks Moving In Wednesday's Mid-Day Session
December 08, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 08, 2021
From Benzinga
Lexaria Bioscience Embarking on Potentially Pivotal Study to Evaluate DehydraTECH-CBD
December 03, 2021
Tickers
LEXX
From Benzinga
Lexaria's DehydraTECH(TM) Demonstrates 10-20X Faster Nicotine Delivery in Recent Study
November 29, 2021
From Benzinga
Lexaria Bioscience's DehydraTECH(TM) Drug Delivery Tech Finding Multiple Applications
November 24, 2021
From Benzinga
Lexaria Bioscience Announces 2022 DehydraTECH(TM) R&D Programs
November 18, 2021
From Benzinga
Lexaria Expands 2022 R&D Programs to Evaluate Alzheimer's, Diabetes
November 11, 2021
Tickers
LEXX
From Benzinga
Lexaria Bioscience Corp. Commences New Animal Study Evaluating Patented DehydraTECH(TM) Technology's Efficacy in Reducing/Inhibiting Seizure Activity
November 04, 2021
From Benzinga
Lexaria Bioscience Corp. to Expand Hypertension Clinical Program Through Most Ambitious Study to Date
November 03, 2021
Tickers
LEXX
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 03, 2021
From Benzinga
Lexaria Bioscience Corp. Begins R&D Program Comparing DehydraTECH-CBD with Generic CBD, Epidiolex
November 02, 2021
Tickers
LEXX
From Benzinga
Lexaria Announces DehydraTECH-CBD Versus Prescription CBD Program In Treating Seizures
November 01, 2021
From Benzinga
Lexaria Bioscience Corp.'s DehydraTECH(TM) Addresses the Needs of Medical THC Users
October 26, 2021
From Benzinga
Lexaria Starts IND-Enabling Program For DehydraTECH-CBD For Hypertension
September 08, 2021
Tickers
LEXX
From Benzinga
From InvestorPlace
CBDNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Results Of Human Clinical Study Showing Effective, Safe BP Reduction
September 07, 2021
From Benzinga
Why Lexaria Bioscience Shares Are Trading Higher Today
September 07, 2021
Tickers
LEXX
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 07, 2021
From Benzinga
Lexaria Bioscience's Formulated Cannabidiol Lowers Blood Pressure In Hypertension Patients
September 07, 2021
Tickers
LEXX
From Benzinga
Lexaria Bioscience Corp. (NASDAQ: LEXX) Targets Burgeoning Hypertension, Antiviral Therapeutics Markets With Drug Delivery Technology
September 02, 2021
From Benzinga
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|